Gabelli Funds’s Lifecore Biomedical LFCR Stock Holding History

Gabelli Funds’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$70.9K	Hold	13,500	–	–	﹤0.01%	1227
2026 Q1	$50.2K	Hold	13,500	–	–	﹤0.01%	1212
2025 Q4	$110K	Hold	13,500	–	–	﹤0.01%	1179
2025 Q3	$99.4K	Hold	13,500	–	–	﹤0.01%	1186
2025 Q2	$110K	Hold	13,500	–	–	﹤0.01%	1168
2025 Q1	$95K	Hold	13,500	–	–	﹤0.01%	1042
2024 Q4	$100K	Sell	13,500 -4,500	-25%	-$28.7K	﹤0.01%	1041
2024 Q3	$88.7K	Sell	18,000 -1,300	-7%	-$6.79K	﹤0.01%	1038
2024 Q2	$99K	Buy	19,300 +300	+2%	+$1.78K	﹤0.01%	1024
2024 Q1	$101K	Buy	19,000 +700	+4%	+$5.01K	﹤0.01%	1027
2023 Q4	$113K	Buy	18,300 +1,700	+10%	+$11.8K	﹤0.01%	1027
2023 Q3	$125K	Hold	16,600	–	–	﹤0.01%	1037
2023 Q2	$161K	Sell	16,600 -400	-2%	-$2.44K	﹤0.01%	1028
2023 Q1	$64.2K	Sell	17,000 -800	-4%	-$4.46K	﹤0.01%	1077
2022 Q4	$115K	Buy	17,800 +300	+2%	+$2.47K	﹤0.01%	1099
2022 Q3	$156K	Hold	17,500	–	–	﹤0.01%	1177
2022 Q2	$174K	Buy	17,500 +4,000	+30%	+$39.6K	﹤0.01%	1200
2022 Q1	$156K	Hold	13,500	–	–	﹤0.01%	1265
2021 Q4	$150K	Sell	13,500 -11,000	-45%	-$107K	﹤0.01%	1283
2021 Q3	$226K	Sell	24,500 -14,500	-37%	-$158K	﹤0.01%	1235
2021 Q2	$439K	Buy	39,000 +10,000	+34%	+$115K	﹤0.01%	1093
2021 Q1	$307K	Buy	29,000 +6,000	+26%	+$67.4K	﹤0.01%	1137
2020 Q4	$250K	Buy	+23,000	New	+$238K	﹤0.01%	1102

Other funds holding LFCR

Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Gabelli Funds's LFCR Position: Q2 2026 in Review

Gabelli Funds held its Lifecore Biomedical (LFCR) position steady in Q2 2026 at 13,500 shares worth $70.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1227.

Gabelli Funds first reported a position in LFCR in Q4 2020 and has held it in 23 quarters since. The position peaked at $439K in Q2 2021. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

Gabelli Funds held 13,500 shares of Lifecore Biomedical worth $70.9K as of Q2 2026.
Gabelli Funds left its Lifecore Biomedical share count unchanged in Q2 2026.
Lifecore Biomedical made up ﹤0.01% of Gabelli Funds's portfolio in Q2 2026, its #1227 holding.
Gabelli Funds first reported a position in Lifecore Biomedical in Q4 2020 and has held it in 23 quarters since.
Gabelli Funds's Lifecore Biomedical position peaked at $439K in Q2 2021.
98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.